Whalerock Point Partners, LLC Bristol Myers Squibb CO Transaction History

Whalerock Point Partners, LLC

$404 Million
Q3 2024

A detailed history of Whalerock Point Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Whalerock Point Partners, LLC holds 6,382 shares of BMY stock, worth $368,624. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,382

Previous 6,532 2.3%

Holding current value

$368,624

Previous $271,000 21.77%

% of portfolio

0.08%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $5,948 - $7,762	-150 Reduced 2.3%	6,382 $330,000
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $213,325 - $280,847	-5,300 Reduced 44.79%	6,532 $271,000
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $6,909 - $7,833	-144 Reduced 1.2%	11,832 $641,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $105,250 - $125,592	-2,171 Reduced 15.35%	11,976 $614,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $15,991 - $17,755	251 Added 1.81%	14,147 $904,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $958 - $1,135	-14 Reduced 0.1%	13,896 $999,000
Q3 2022 Nov 16, 2022	BUY	$0.13 - $76.84 $1,679 - $992,849	12,921 Added 1306.47%	13,910 $989,000
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $1,679 - $992,849	-12,921 Reduced 92.89%	989 $989 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $27,481 - $32,952	-447 Reduced 3.11%	13,910 $1.02 Billion
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $52,932 - $61,707	-987 Reduced 6.43%	14,357 $895,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $4,319 - $5,059	-73 Reduced 0.47%	15,344 $908,000
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Reduced 0.64%	15,417 $1.03 Billion
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $842,599 - $954,819	14,593 Added 1579.33%	15,517 $963,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $963,962 - $1.07 Million	-16,785 Reduced 94.78%	924 $55,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $754,049 - $881,557	-13,755 Reduced 43.72%	17,709 $1.04 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $23,200 - $33,715	-500 Reduced 1.56%	31,464 $1.75 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $42,172 - $55,010	857 Added 2.76%	31,964 $2.05 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $27,072 - $32,280	600 Added 1.97%	31,107 $1.48 Million
Q2 2018 Mar 04, 2019	SELL	$50.53 - $62.98 $98,533 - $122,811	-1,950 Reduced 6.01%	30,507 $1.69 Million
Q4 2017 Jan 16, 2018	SELL	$59.94 - $65.35 $68,451 - $74,629	-1,142 Reduced 3.4%	32,457 $1.99 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $1.86 Million - $2.14 Million	33,599	33,599 $2.14 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whalerock Point Partners, LLC with notifications on news.

Account

Whalerock Point Partners, LLC Bristol Myers Squibb CO Transaction History